Abstract:ABSTRACT Tuberculous meningitis (TBM) is a severe infectious disease affecting the central nervous system, causing high mortality and disability. However, current diagnostic methods for TBM using cerebrospinal fluid (CSF) lack sensitivity and predictive biomarkers for prognosis. We conducted a study on cytokine profiles in CSF and serum samples from TBM patients to identify disease-specific biomarkers. Patients were categorized into three groups: TBM ( n = 17), cryptococcal meningitis ( n = 10), and non-infection ( n = 6), and cytokine levels were quantified using a 48-plex panel. After treatment, we observed a significant reduction in the levels of 12 cytokines, indicating their potential use as biomarkers for treatment monitoring. Among them, monokine induced by interferon-γ (MIG) and interleukin-18 showed significant differences in serum or CSF cytokine levels compared to the control groups. CSF levels of MIG in TBM patients were negatively correlated with the CSF/blood glucose ratio ( r = −0.4728, P = 0.0475). Positive correlations were found between CSF leukocyte counts and several cytokines, including fibroblast growth factor-basic, granulocyte colony-stimulating factor (G-CSF), monocyte chemotactic protein-3, macrophage inflammatory protein 1 alpha (MIP-1α), and tumor necrosis factor alpha. G-CSF and MIP-1α were also positively correlated with CSF protein levels. Receiver operating characteristic curve analysis revealed that MIG exhibited the highest area under the curve of 0.92 [95% confidence interval (CI) 0.82–1.00] with a sensitivity of 0.85 (95% CI 0.58–0.97) and a specificity of 0.87 (95% CI 0.62–0.98), making it a promising diagnostic biomarker for TBM. Our study provides valuable insights into TBM’s pathogenesis and identifies potential biomarkers for diagnosis and evaluating treatment monitoring. IMPORTANCE Tuberculous meningitis is a life-threatening infection with high mortality and disability rates. Current diagnostic methods using cerebrospinal fluid (CSF) samples have limited sensitivity and lack predictive biomarkers for evaluating prognosis. This study’s findings reveal excessive activation of the immune response during tuberculous meningitis (TBM) infection. Notably, a strong negative correlation was observed between CSF levels of monokine induced by interferon-γ (MIG) and the CSF/blood glucose ratio in TBM patients. MIG also exhibited the highest area under the curve with high sensitivity and specificity. This study suggests that MIG may serve as a novel biomarker for differentiating TBM infection in CSF or serum, potentially leading to improved diagnostic accuracy and better patient outcomes.

Identification of protein biomarkers in host cerebrospinal fluid for differential diagnosis of tuberculous meningitis and other meningitis

Systemic and cerebrospinal fluid biomarkers for tuberculous meningitis identification and treatment monitoring

Global Protein Differential Expression Profiling of Cerebrospinal Fluid Samples Pooled from Chinese Sporadic CJD and non-CJD Patients

Cerebrospinal Fluid Metabolomic Profiling in Tuberculous and Viral Meningitis: Screening Potential Markers for Differential Diagnosis

Sensitivity and specificity of immunocytochemical staining of mycobacterial antigens in the cytoplasm of cerebrospinal fluid macrophages for diagnosing tuberculous meningitis.

Elevated Host Lipid Metabolism Revealed by Itraq-Based Quantitative Proteomic Analysis of Cerebrospinal Fluid of Tuberculous Meningitis Patients.

Genome-Wide Mirna Analysis Identifies Potential Biomarkers in Distinguishing Tuberculous and Viral Meningitis

Early diagnosis of tuberculous meningitis new methods:detection concentration in cerebrospinal fluid CFP-10 and ESAT-6

Diagnostic Model for Discrimination Between Tuberculous Meningitis and Bacterial Meningitis

Screening the Cytokines for Diagnosis of Tuberculous Meningitis

An Itraq Approach to Quantitative Proteome Analysis of Cerebrospinal Fluid from Patients with Tuberculous Meningitis.

Tuberculostearic acid incorporated predictive model contributes to the clinical diagnosis of tuberculous meningitis

Clinical Diagnostic Significance of ESAT-6, IL-10, TNF-α and IFN-γ in Tuberculous Meningitis

The application value of cerebrospinal fluid immunoglobulin in tuberculous meningitis

Interferon-Gamma Release Assay Performance of Cerebrospinal Fluid and Peripheral Blood in Tuberculous Meningitis in China.

Comparative Evaluation of Early Diagnosis of Tuberculous Meningitis by Different Assays.

The Feasibility of Metagenomic Next-Generation Sequencing to Identify Pathogens Causing Tuberculous Meningitis in Cerebrospinal Fluid

IgG response to Mycobacterium tuberculosis non-polar lipids and sonicated extracts among tuberculous meningitis patients

Serum and cerebrospinal fluid host proteins indicate stroke in children with tuberculous meningitis

Characterization of cytokine profile to distinguish latent tuberculosis from active tuberculosis and healthy controls.

Development and Validation of a New Scoring System for the Early Diagnosis of Tuberculous Meningitis in Adults